APPLICATIONS PUBLISHED 20 JULY 2005

Quick dissolve compsns and tablets based thereon
Bioavail Technologies; Mexaache, Naima, Frisbee, Steven; Woodall, Patrick; Herman, Mark 1553909*

2-heterosubstituted 3-aryl-4-H-1-benzopyran as novel therapeutics in breast cancer
The Ohio State University Research Foundation 1553911*

Compnsn and methods for the diagnosis and treatment of tumour
Genentech 1553912*

Novel method of stabilising diagnostic and therapeutic compounds in a cationic carrier system
MediGene Oncology 1553924*

Gel-stabilised nanoparticulate active agent compsns
Elan Pharma International 1553927*

Oral pharmaceutical compsns of fenofibrate having high bioavailability
Ranbaxy Laboratories 1553928*

Controlled release preparation
Takeda Pharmaceutical 1553929*

Compounds, compsns and methods
Cytokinetics; SmithKline Beecham 1553931*

Derivatives of N-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators
Ramot at Tel Aviv University 1553932*

Medicine comprising a thiourea for use as depigmenting agent or antimutagenic and anticarcinogenic agent
LMD 1553933*

Pharmaceutical compsn for treating pain comprising oxicarbazepine, or derivatives thereof, and COX2 inhibitors
Novartis 1553934*

Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
The University of Washington 1553935*

Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods
Bristol-Myers Squibb 1553937*

Use of epothilone derivatives for the treatment of hyperparathyroidism
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College 1553938*

Epothilone derivatives for the treatment of multiple myeloma
Dana-Farber Cancer Institute 1553939*

Parenteral formulations containing a rapamycin hydroxyester
Wyeth 1553940*

Lisinopril/lercanidipine combination therapy
Recordati Ireland 1553941*

Pharmaceutical compsn combining tenatoprazole and an anti-inflammatory agent
Sidem Pharma; Mitsubishi Pharma 1553942*

Nitroxide radioprotector formulations and methods of use
Mitos Pharmaceuticals 1553945*

Enhancement of sleep with T-type calcium channel antagonists
Merck 1553946*

Quinazolinones and derivatives thereof as factor XA inhibitors
Bristol-Myers Squibb 1553947*

Combination of A) N-(5-(5-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4,(3-pyridyl)-2-pyrimidine-amine and B) a histone deacetylase inhibitor for the treatment of leukaemia
Virgina Commonwealth University; McGuire Va Medical Center 1553948*

Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
Warner-Lambert 1553949*

Therapeutic treatment
AstraZeneca 1553950*

Methods of using and compsns comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
Celgene 1553951*

Method and compsn containing latanoprost for treating ocular hypertension and glaucoma
Sucampo Ag 1553953*

Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compsns thereof
Epigenesis Pharmaceuticals 1553954*

Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
Combinatorz; Manivasakam, Planiyandi; Smith, Brendan; Fong, Jason; Auspitz, Benjamin; Nichols, M James; Keith, Curtis; Zimmerman, Grant; Brasher, Bradley; Sachs, Noah; Chappel, Todd 1553955*

Formulation for lipophilic agents
Bone Care International 1553956*

Bisphosphonates for the treatment of atherosclerosis and devices comprising them
Novartis 1553957*

Method of administering bisphosphonates
Novartis 1553958*

Method for extracting a natural mixture of conjugated equine estrogens that is depleted of non-conjugated lipophilic compounds
Solvay Pharmaceuticals 1553959*

Neuregulin based methods and compounds for treating cardiovascular disease
Zensyn (Shanghai) Sci-Tech 1553960*

Use of enteric glia to promote functional nerve connections
Neurological Technologies 1553961*

Combination chemotherapy with chlorotoxin
Transmolecular 1553962*

Novel agents that modulate EPH receptor activity
The Burnham Institute 1553963*

Ketoamine inhibitors in chronic nerve disease
Georgia Tech Research Corp 1553964*

Method of treating tumours
The Regents of the University of California; Merck Patent 1553965*

Human papilloma virus polypeptides and immunogenic compsns
Wyeth Holdings 1553966*

Use of amide derivative of GE 2270 factor A3 for the treatment of acne
Vicuron Pharmaceuticals 1553967*

Use of ghrelin for treating malnutrition in gastroectomised individuals
Gastrotech Pharma 1553969*

Treatment of allergic compsns by use of IL 21
Novo Nordisk 1553970*

Therapies for renal failure using interferon-B
Biogen Idec 1553971*

Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin
Milkhaus Laboratory 1553972*

Pharmaceutical compsn comprising carriers for products
Santana, Cristiano Alberto Ribeiro; de Nucci, Gilberto 1553974*

Optimised FC variants and methods for their generation
Xencor 1553975*